REX vs XRAY · P/E 15, rev $642.5M vs rev $3.68B
REX American Resources Corporation (REX) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
REX American Resources Corporation (REX) is a chemicals company listed on NYSE.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported REX revenue for 2025-01-31 was $642.5M. Net income was $71.5M. Revenue was down 22.9% from 2024-01-31 to 2025-01-31. REX currently screens at market cap $1.43B and trailing P/E 15.5.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
REX currently screens at market cap $1.43B and trailing P/E 15.5. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the REX and XRAY stock pages for the full models.
Not investment advice.